<i>Strongyloides</i>-Specific IgE Phage cDNA Clones and Development of a Novel ELISA for Strongyloidiasis

Strongyloidiasis, caused mainly by the nematode <i>Strongyloides stercoralis</i>, is prevalent worldwide and potentially fatal in immunosuppressed patients. We report on a new IgE biomarker to diagnose <i>Strongyloides</i> infection. Sera from two groups infected with <i&g...

Full description

Bibliographic Details
Main Authors: Hussain Ahmad, Norsyahida Arifin, Thomas J. Nolan, James B. Lok, Nor Suhada Anuar, Rahmah Noordin
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/11/6/985
id doaj-b3d0567edbff41c79bb4358ff2f40b7f
record_format Article
spelling doaj-b3d0567edbff41c79bb4358ff2f40b7f2021-06-01T01:33:33ZengMDPI AGDiagnostics2075-44182021-05-011198598510.3390/diagnostics11060985<i>Strongyloides</i>-Specific IgE Phage cDNA Clones and Development of a Novel ELISA for StrongyloidiasisHussain Ahmad0Norsyahida Arifin1Thomas J. Nolan2James B. Lok3Nor Suhada Anuar4Rahmah Noordin5Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Penang 11800, MalaysiaInstitute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Penang 11800, MalaysiaDepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USADepartment of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USAInstitute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Penang 11800, MalaysiaInstitute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Penang 11800, MalaysiaStrongyloidiasis, caused mainly by the nematode <i>Strongyloides stercoralis</i>, is prevalent worldwide and potentially fatal in immunosuppressed patients. We report on a new IgE biomarker to diagnose <i>Strongyloides</i> infection. Sera from two groups infected with <i>Strongyloides</i> served as positive samples: Group 1A, in which infection was confirmed by stool-microscopy and/or stool-polymerase chain reaction (PCR) and was seropositive by an IgG-enzyme linked immunosorbent assay (ELISA) and an IgG4 rapid test, and Group 1B in which infection was confirmed by stool-PCR but was seronegative. Negative samples (controls) comprised infections with other parasites (Group II) and healthy donors (Group III). Immunoscreenings of an <i>S. stercoralis</i> complementary DNA (cDNA) library were performed, and the cDNA clone with the highest diagnostic potential (clone A133) was selected for recombinant protein production and then evaluated using IgE Western blot and ELISA. The Western blot showed that the recombinant protein (rA133) was 100% reactive with Group IA (<i>n </i>= 10) and Group IB (<i>n </i>= 5), and 96% non-reactive with Groups II and III (<i>n </i>= 25). Subsequently, the IgE-ELISA was developed and showed 100% diagnostic sensitivity in Groups IA (<i>n </i>= 32) and IB (<i>n </i>= 11); and 99.3% specificity in Groups II and III (<i>n </i>= 144). In conclusion, this study has identified rA133 as a novel recombinant protein with potential diagnostic value, and that the IgE-ELISA incorporating this protein may be useful for patient diagnosis and epidemiological studies.https://www.mdpi.com/2075-4418/11/6/985<i>Strongyloides stercoralis</i>strongyloidiasisimmunoscreeningcomplementary DNA (cDNA) libraryrecombinant antigenserodiagnosis
collection DOAJ
language English
format Article
sources DOAJ
author Hussain Ahmad
Norsyahida Arifin
Thomas J. Nolan
James B. Lok
Nor Suhada Anuar
Rahmah Noordin
spellingShingle Hussain Ahmad
Norsyahida Arifin
Thomas J. Nolan
James B. Lok
Nor Suhada Anuar
Rahmah Noordin
<i>Strongyloides</i>-Specific IgE Phage cDNA Clones and Development of a Novel ELISA for Strongyloidiasis
Diagnostics
<i>Strongyloides stercoralis</i>
strongyloidiasis
immunoscreening
complementary DNA (cDNA) library
recombinant antigen
serodiagnosis
author_facet Hussain Ahmad
Norsyahida Arifin
Thomas J. Nolan
James B. Lok
Nor Suhada Anuar
Rahmah Noordin
author_sort Hussain Ahmad
title <i>Strongyloides</i>-Specific IgE Phage cDNA Clones and Development of a Novel ELISA for Strongyloidiasis
title_short <i>Strongyloides</i>-Specific IgE Phage cDNA Clones and Development of a Novel ELISA for Strongyloidiasis
title_full <i>Strongyloides</i>-Specific IgE Phage cDNA Clones and Development of a Novel ELISA for Strongyloidiasis
title_fullStr <i>Strongyloides</i>-Specific IgE Phage cDNA Clones and Development of a Novel ELISA for Strongyloidiasis
title_full_unstemmed <i>Strongyloides</i>-Specific IgE Phage cDNA Clones and Development of a Novel ELISA for Strongyloidiasis
title_sort <i>strongyloides</i>-specific ige phage cdna clones and development of a novel elisa for strongyloidiasis
publisher MDPI AG
series Diagnostics
issn 2075-4418
publishDate 2021-05-01
description Strongyloidiasis, caused mainly by the nematode <i>Strongyloides stercoralis</i>, is prevalent worldwide and potentially fatal in immunosuppressed patients. We report on a new IgE biomarker to diagnose <i>Strongyloides</i> infection. Sera from two groups infected with <i>Strongyloides</i> served as positive samples: Group 1A, in which infection was confirmed by stool-microscopy and/or stool-polymerase chain reaction (PCR) and was seropositive by an IgG-enzyme linked immunosorbent assay (ELISA) and an IgG4 rapid test, and Group 1B in which infection was confirmed by stool-PCR but was seronegative. Negative samples (controls) comprised infections with other parasites (Group II) and healthy donors (Group III). Immunoscreenings of an <i>S. stercoralis</i> complementary DNA (cDNA) library were performed, and the cDNA clone with the highest diagnostic potential (clone A133) was selected for recombinant protein production and then evaluated using IgE Western blot and ELISA. The Western blot showed that the recombinant protein (rA133) was 100% reactive with Group IA (<i>n </i>= 10) and Group IB (<i>n </i>= 5), and 96% non-reactive with Groups II and III (<i>n </i>= 25). Subsequently, the IgE-ELISA was developed and showed 100% diagnostic sensitivity in Groups IA (<i>n </i>= 32) and IB (<i>n </i>= 11); and 99.3% specificity in Groups II and III (<i>n </i>= 144). In conclusion, this study has identified rA133 as a novel recombinant protein with potential diagnostic value, and that the IgE-ELISA incorporating this protein may be useful for patient diagnosis and epidemiological studies.
topic <i>Strongyloides stercoralis</i>
strongyloidiasis
immunoscreening
complementary DNA (cDNA) library
recombinant antigen
serodiagnosis
url https://www.mdpi.com/2075-4418/11/6/985
work_keys_str_mv AT hussainahmad istrongyloidesispecificigephagecdnaclonesanddevelopmentofanovelelisaforstrongyloidiasis
AT norsyahidaarifin istrongyloidesispecificigephagecdnaclonesanddevelopmentofanovelelisaforstrongyloidiasis
AT thomasjnolan istrongyloidesispecificigephagecdnaclonesanddevelopmentofanovelelisaforstrongyloidiasis
AT jamesblok istrongyloidesispecificigephagecdnaclonesanddevelopmentofanovelelisaforstrongyloidiasis
AT norsuhadaanuar istrongyloidesispecificigephagecdnaclonesanddevelopmentofanovelelisaforstrongyloidiasis
AT rahmahnoordin istrongyloidesispecificigephagecdnaclonesanddevelopmentofanovelelisaforstrongyloidiasis
_version_ 1721412149363867648